Retrophin, LLC Announces Pricing Of Public Offering Of Common Shares
NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX)(formerly OTCQB:RTRX) today announced the pricing of an underwritten public offering of 4,705,882 shares of its common stock, offered at a price of $8.50 per share. The gross proceeds from this offering, before underwriting discounts and commissions and other offering expenses, are expected to be approximately $40,000,000. The offering is expected to close on or about January 15, 2014, subject to customary closing conditions. Retrophin also granted the underwriter a 30-day option to purchase 705,882 additional shares of its common stock.
Help employers find you! Check out all the jobs and post your resume.